Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) has commenced an underwritten public offering of 4,250,000 shares of its common stock. In ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE